首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1746588

日本重組蛋白市場報告（按產品、應用、最終用戶和地區）2025-2033

Japan Recombinant Protein Market Report by Product, Application, End User, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 115 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本重組蛋白市場規模達2.657億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到5.737億美元，2025-2033年期間的複合年成長率（CAGR）為8.9%。單株抗體、疫苗和治療性蛋白質等生物製藥的蓬勃發展，正推動著市場的發展，這些生物製藥擴大被用於治療各種疾病，包括癌症、自體免疫疾病和傳染病。

重組蛋白是透過結合不同來源的遺傳物質（通常是來自具有產生特定蛋白質能力的生物體的DNA和宿主生物體用於蛋白質生產的細胞機制）而產生的人工工程蛋白質。該過程是生物技術和製藥行業不可或缺的一部分，可用於大規模生產用於各種應用的特定蛋白質。為了創建重組蛋白，科學家將所需的基因序列插入宿主生物體，例如細菌、酵母或哺乳動物細胞。一旦宿主生物體吸收了外來DNA，它就會根據插入的遺傳指令開始生產目標蛋白質。重組蛋白具有廣泛的應用，包括生產治療藥物（例如胰島素或疫苗）、研究工具（例如酵素和抗體）以及用於各種製程（例如生物燃料生產或食品加工）的工業酵素。它們的生產具有精確控制、可擴展性和純度，使其成為醫療、科學和工業領域發展的關鍵。

日本重組蛋白市場趨勢：

推動日本重組蛋白市場發展的因素很多。首先，癌症、糖尿病和自體免疫疾病等慢性疾病的發生率不斷上升，使得透過重組DNA技術生產的治療性蛋白質的需求日益成長。因此，製藥公司正大力投資新型態生物製藥的開發，推動市場發展。此外，基因工程和生物技術的進步也改進了重組蛋白的生產過程。哺乳動物和酵母細胞係等增強表達系統使得能夠生產產量更高、品質更好的複雜蛋白質，從而推動了市場擴張。此外，蛋白質體學和基因組學領域研發活動的激增，也刺激了重組蛋白作為研究工具的需求。這些蛋白質對於研究基因功能、蛋白質-蛋白質相互作用和藥物研發至關重要，從而促進了市場成長。此外，個人化醫療的採用以及雙特異性抗體和融合蛋白的開發為治療性蛋白質產業開闢了新的機遇，預計將在預測期內推動日本重組蛋白市場的發展。

日本重組蛋白市場細分：

產品洞察：

抗體
荷爾蒙
生長因子
細胞因子
其他

應用程式洞察：

藥物研發
學術研究
生物技術研究
生物製藥生產
其他

最終用戶洞察：

製藥和生物製藥公司
生技公司
學術和研究機構
合約研究組織
其他

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本重組蛋白市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本重組蛋白市場有何影響？
日本重組蛋白市場依產品分類是怎樣的？
日本重組蛋白市場根據應用如何分類？
根據最終用戶，日本重組蛋白市場是如何分類的？
日本重組蛋白市場的價值鏈分為哪些階段？
日本重組蛋白的關鍵促進因素和挑戰是什麼？
日本重組蛋白市場的結構是怎麼樣的？主要參與者是誰？
日本重組蛋白市場的競爭程度如何？

本報告回答的關鍵問題：

日本重組蛋白市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本重組蛋白市場有何影響？
日本重組蛋白市場依產品分類是怎樣的？
日本重組蛋白市場根據應用如何分類？
根據最終用戶，日本重組蛋白市場是如何分類的？
日本重組蛋白市場的價值鏈分為哪些階段？
日本重組蛋白的關鍵促進因素和挑戰是什麼？
日本重組蛋白市場的結構是怎麼樣的？主要參與者是誰？
日本重組蛋白市場的競爭程度如何？

Japan recombinant protein market size reached USD 265.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 573.7 Million by 2033, exhibiting a growth rate (CAGR) of 8.9% during 2025-2033. The inflating development of biopharmaceuticals, such as monoclonal antibodies, vaccines, and therapeutic proteins, which are increasingly being used to treat various illnesses, including cancer, autoimmune disorders, and infectious diseases, is driving the market.

Recombinant protein are artificially engineered proteins created by combining genetic material from different sources, typically DNA from one organism with the ability to produce a specific protein and the host organism's cellular machinery for protein production. This process is integral to the biotechnology and pharmaceutical industries, allowing the large-scale production of specific proteins for various applications. To create recombinant proteins, scientists insert the desired gene sequence into a host organism, like bacteria, yeast, or mammalian cells. Once the host organism takes up the foreign DNA, it begins producing the target protein according to the inserted genetic instructions. Recombinant proteins have diverse applications, including the production of therapeutic drugs (e.g., insulin or vaccines), research tools (e.g., enzymes and antibodies), and industrial enzymes for various processes (e.g., biofuel production or food processing). Their production allows for precise control, scalability, and purity, making them essential in advancing medical, scientific, and industrial fields.

Japan Recombinant Protein Market Trends:

Several factors drive the recombinant protein market in Japan. Firstly, the increasing incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders has created a growing demand for therapeutic proteins produced through recombinant DNA technology. Consequently, pharmaceutical companies are heavily investing in the development of novel biopharmaceuticals, propelling the market forward. Furthermore, advancements in genetic engineering and biotechnology have led to improved production processes for recombinant proteins. Enhanced expression systems, such as mammalian and yeast cell lines, have enabled the production of complex proteins with higher yields and better quality, driving market expansion. In addition to this, the surge in R&D activities in the field of proteomics and genomics has boosted the demand for recombinant proteins as research tools. These proteins are essential for studying gene function, protein-protein interactions, and drug discovery, fostering market growth. Moreover, the adoption of personalized medicine and the development of bi-specific antibodies and fusion proteins, which have opened up new opportunities in the therapeutic protein industry, is expected to drive the recombinant protein market in Japan during the forecast period.

Japan Recombinant Protein Market Segmentation:

Product Insights:

Antibodies
Hormones
Growth Factors
Cytokines
Others

Application Insights:

Drug Discovery and Development
Academic Research
Biotechnology Research
Biopharmaceutical Production
Others

End User Insights:

Pharmaceutical and Biopharmaceutical Companies
Biotechnology Companies
Academic and Research Institutes
Contract Research Organization
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan recombinant protein market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan recombinant protein market?
What is the breakup of the Japan recombinant protein market on the basis of product?
What is the breakup of the Japan recombinant protein market on the basis of application?
What is the breakup of the Japan recombinant protein market on the basis of end user?
What are the various stages in the value chain of the Japan recombinant protein market?
What are the key driving factors and challenges in the Japan recombinant protein?
What is the structure of the Japan recombinant protein market and who are the key players?
What is the degree of competition in the Japan recombinant protein market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Recombinant Protein Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Recombinant Protein Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Recombinant Protein Market - Breakup by Product

6.1 Antibodies
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Hormones
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Growth Factors
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
6.4 Cytokines
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
6.5 Others
- 6.5.1 Historical and Current Market Trends (2019-2024)
- 6.5.2 Market Forecast (2025-2033)

7 Japan Recombinant Protein Market - Breakup by Application

7.1 Drug Discovery and Development
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Academic Research
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Biotechnology Research
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Biopharmaceutical Production
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2019-2024)
- 7.5.2 Market Forecast (2025-2033)

8 Japan Recombinant Protein Market - Breakup by End User

8.1 Pharmaceutical and Biopharmaceutical Companies
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Biotechnology Companies
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Academic and Research Institutes
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Contract Research Organization
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)

9 Japan Recombinant Protein Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Recombinant Protein Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis